Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy

British Journal of Cancer

Volumn 103, Issue 7, 2010, Pages 1081-1084

  Dores, G M ^a,b   Anderson, W F ^b   Beane Freeman, L E ^b   Fraumeni Jr , J F ^b   Curtis, R E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hodgkins lymphoma; radiation related breast cancer; second breast cancer

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CLINICAL FEATURE; COMPARATIVE STUDY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; BREAST NEOPLASMS; CANCER REGISTRY; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; SURVIVOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HODGKIN DISEASE; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RISK FACTORS; SEER PROGRAM; SURVIVORS;

EID: 77957223564     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605877     Document Type: Article

References (22)

1. Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76: 27-36 (Pubitemid 35178626)
2. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA (2001) Tumor variants by hormone receptor expression in white patients with nodenegative breast cancer from the surveillance, epidemiology, and end results database. J Clin Oncol 19: 18-27 (Pubitemid 32063475)
3. Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T, Sozzi G, Fossati-Bellani F, Menard S, Tagliabue E (2007) Radiation effects on development of HER2-positive breast carcinomas. Clin Cancer Res 13: 46-51 (Pubitemid 46121851)
4. Curtis RE, Ries LAG (2006) Methods. In New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973 -2000, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA & Fraumeni JF Jr (eds) pp. 9-14. National Cancer Institute, NIH Publ. No.05-5302: Bethesda
5. Devesa SS, Donaldson J, Fears T (1995) Graphical presentation of trends in rates. Am J Epidemiol 141: 300-304
6. Diller L, Medeiros Nancarrow C, Shaffer K, Matulonis U, Mauch P, Neuberg D, Tarbell NJ, Litman H, Garber J (2002) Breast cancer screening in women previously treated for Hodgkins disease: a prospective cohort study. J Clin Oncol 20: 2085-2091 (Pubitemid 34408799)
7. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, vant Veer MB, Stovall M, Gospodarowicz M, Travis LB (2002) Second malignant neoplasms among long-term survivors of Hodgkins disease: a population-based evaluation over 25 years. J Clin Oncol 20: 3484-3494
8. Fisher B, Cheung AY (1984) Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkins disease. Acta Radiol Oncol 23: 43-48 (Pubitemid 14102334)
9. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International Classification of Diseases for Oncology. World Health Organization: Geneva, Switzerland
10. Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL (2001) Breast cancer after mantle irradiation for Hodgkins disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys 49: 539-546 (Pubitemid 32120254)
11. Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fossa SD, Travis LB (2007) Long-term solid cancer risk among 5-year survivors of Hodgkins lymphoma. J Clin Oncol 25: 1489-1497 (Pubitemid 46759253)
12. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151: 703-714 (Pubitemid 30463592)
13. Janov AJ, TuleckeM, ONeill A, Lester S, Mauch PM, Harris J, Schnitt SJ, Shapiro CL (2001) Clinical and pathologic features of breast cancers in women treated for Hodgkins disease: a case-control study. Breast J 7: 46-52 (Pubitemid 32162847)
14. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL, Ursin G, Marchbanks PA, McDonald JA, Spirtas R, Press MF, Bernstein L (2009) Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18: 2214-2220
15. Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL (2009) Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 301: 404-414
16. Preston DL, Lubin JH, Pierce DA (1993). Epicure users guide: Seattle, WA
17. Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, Nole F, Goldhirsch A (2007) Breast cancer in Hodgkins disease and non- Hodgkins lymphoma survivors. Ann Oncol 18: 288-292 (Pubitemid 46323095)
18. SEER-9 (2008) Surveillance, Epidemiology and End Results (SEER) Program. ( www.seer.cancer.gov ) SEER Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2007 Sub (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission
19. Trichopoulos D, MacMahon B, Cole P (1972) Menopause and breast cancer risk. J Natl Cancer Inst 48: 605-613
20. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT (2000) Management of breast cancer after Hodgkins disease. J Clin Oncol 18: 765-772 (Pubitemid 30106606)
21. Yahalom J, Petrek JA, Biddinger PW, Kessler S, Dershaw DD, McCormick B, Osborne MP, Kinne DA, Rosen PP (1992) Breast cancer in patients irradiated for Hodgkins disease: a clinical and pathologic analysis of 45 events in 37 patients (see comments). J Clin Oncol 10: 1674-1681 (Pubitemid 23059943)
22. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL (2003) A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 158: 1108-1113 (Pubitemid 37475095)